ArticleOncotarget2015
The cytotoxic effects of regorafenib in combination with protein kinase D inhibition in human colorectal cancer cells.
Ning Wei et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this papercites it